U.S. Sex Reassignment Hormone Therapy Market Size Report, 2032

U.S. Sex Reassignment Hormone Therapy Market – By Gender Transition (Male-To-Female, Female-To-Male), Type (Estrogen, Testosterone, Puberty Blockers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing awareness and acceptance about sex reassignment treatments

3.2.1.2&nbsp;&nbsp;&nbsp; Rise in availability of novel hormonal therapies with better efficacy

3.2.1.3&nbsp;&nbsp;&nbsp; Rising number of gender-affirming surgeries

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Ambiguous regulatory scenario for sex reassignment drugs

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.6&nbsp;&nbsp;&nbsp; LGBT scenario

3.7&nbsp;&nbsp;&nbsp; Technology landscape

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

3.10&nbsp;&nbsp;&nbsp; Future market trends

3.11&nbsp;&nbsp;&nbsp; Gap analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Gender Transition, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Male-To-Female (MTF)

5.3&nbsp;&nbsp;&nbsp; Female-To-Male (FTM)

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Estrogen

6.3&nbsp;&nbsp;&nbsp; Testosterone

6.4&nbsp;&nbsp;&nbsp; Puberty blockers

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

7.3&nbsp;&nbsp;&nbsp; Retail pharmacies

7.4&nbsp;&nbsp;&nbsp; Online pharmacies

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Zone, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; East North Central

8.3&nbsp;&nbsp;&nbsp; West South Central

8.4&nbsp;&nbsp;&nbsp; South Atlantic

8.5&nbsp;&nbsp;&nbsp; North East

8.6&nbsp;&nbsp;&nbsp; East South Central

8.7&nbsp;&nbsp;&nbsp; West North Central

8.8&nbsp;&nbsp;&nbsp; Pacific Central

8.9&nbsp;&nbsp;&nbsp; Mountain States

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles 

9.1&nbsp;&nbsp;&nbsp; ASCEND Therapeutics US, LLC

9.2&nbsp;&nbsp;&nbsp; BIOTE MEDICAL, LLC

9.3&nbsp;&nbsp;&nbsp; Eli Lilly and Company

9.4&nbsp;&nbsp;&nbsp; Endo International plc

9.5&nbsp;&nbsp;&nbsp; Novartis AG

9.6&nbsp;&nbsp;&nbsp; Noven Pharmaceuticals, Inc.

9.7&nbsp;&nbsp;&nbsp; Novo Nordisk A/S

9.8&nbsp;&nbsp;&nbsp; Pfizer Inc.

9.9&nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd.

9.10&nbsp;&nbsp;&nbsp; Viatris Inc.

&nbsp;&nbsp;&nbsp;

US Sex Reassignment Hormone Therapy Market

Get a free sample of this report